ImmunoGen Inc
ImmunoGen is now part of AbbVie. Follow @AbbVieGlobal for future updates.
Community Guidelines
Review AbbVie's Facebook and other global social media community guidelines here: https://www.abbvie.com/social-media-community-guidelines.html AbbVie's mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people's lives. Our commitment is measured by the impact we make - on patients, communities, and our world -
ImmunoGen is officially part of AbbVie. Together, we'll work to help advance treatment options - aiming to disrupt the progression of this disease and offering patients more good days. Follow AbbVie for all future updates and learn more: https://bit.ly/3OF7Tdq
08/02/2024
Last week we held our first All Company Meeting of 2024! came together to hear updates from our CEO, Mark Enyedy, sit in on a fireside chat led by Michael Method with an survivor named Susanna, and gain insight from our COO, Isabel Kalofonos, on our commercial activities. We're ready and excited for all of the growth and expansion ahead in 2024 – and beyond.
At the age of 27, Jess was living in Oklahoma City. She enjoyed her job at a medical research foundation but often wondered, “Is this all there is?” Jess was always dreaming of being somewhere else. Ultimately, a life-changing diagnosis in 2016 would take her to places she never would have dreamed of – including the top of the world. We invite you to watch Jess’ story, called The Climb: https://bit.ly/492dtyM.
02/02/2024
is this Sunday – an opportunity to raise awareness about the importance of early detection and prevention, and provide support for those affected. We understand that is relentless, which is why we will work together to help , remove health inequities and enable access to healthcare services deserved by all. Learn how you can get involved and help create change in cancer care: https://www.worldcancerday.org/close-care-gap.
Introducing our Finance Team – a talented group of folks who serve as strategic financial partners to across all aspects of the business, ranging from financial planning and analysis to accounting and reporting. They ensure we can continuously innovate and develop targeted therapies to bring to with .
Introducing Missy Richard, who has contributed three decades to as an Executive Assistant! Her role involves facilitating schedules, managing tasks, and ensuring efficient workflows for our Regulatory Affairs, Technical Operations, and Quality teams. We are lucky to have her on board as we work to deliver targeted therapies to living with .
28/12/2023
As we wrap up 2023, we’d like to thank each member of for their contributions to bringing the business to where it is today, while working relentlessly to offer with . The last 12 months have been remarkable and a testament to our collective superlative performance. We look forward in continuing to deliver on the business in 2024!
Our Commercial Strategy and Operations team is responsible for all things brand planning, launch readiness, marketing operations, field force effectiveness, and insights and analytics. We appreciate everything they do to bring to with – every day.
Meet Dr. Fabian Zohren, ’s new Chief Medical Officer. He brings more than two decades of experience spanning all facets of clinical research, patient care, and drug development. We are thrilled to have him on board as we seek to develop targeted therapies and deliver to with .
Sometimes, things happen when you least expect it – and not for the best. Watch as Nick shares his journey from diagnosis to treatment and recovery from a rare and aggressive known as . His story motivates everyone on to work unrelentingly to bring to people with cancer. We invite you to watch Nick’s story, called Nothing’s Promised: https://www.youtube.com/watch?v=VE027O9RJ2E
Welcome Heather Huet! Our new CSO has a wealth of expertise in the field of ADCs. We look forward to her leadership in helping deliver the next generation of clinical candidates through innovative research and building our R&D organization.
Introducing our EHS and Facilities Team! These dedicated individuals work behind the scenes to keep our facilities running smoothly while supporting our workplace safety by ensuring compliance with regulations, mitigating risks, and keeping our physical space in tip-top shape. Thank you for all that you do!
17/10/2023
Last week, we brought together for an All Company Meeting to reflect on and celebrate our recent achievements. Mark Enyedy offered insight into business performance, Mike Vasconcelles provided color on our R&D strategy, and an survivor, Laura, shared her personal story. We’re excited for what’s to come in 2024 as we work to bring targeted therapies to in need around the world.
10/10/2023
Today, we're recognizing . ’s whole person health remains our priority today and every day – it’s why we offer a broad range of benefits, including employee assistance and wellness programs, and cover 100% of mental health care both in and out of network for all our employees.
06/10/2023
We’re proud to be a platinum sponsor for the American Cancer Society's 15th annual Boston Key Gala on October 16. Each year, this event supports the Boston Hope Lodge, which serves as a home away from home for undergoing treatment. Enabling patients to gain access to the care they need while offering support and a direct connection with others facing the same journey – that’s a cause we can get behind.
We exist to interrupt the progress of so cancer can’t interrupt the lives of our . This is why month is important to – and why working relentlessly to develop targeted therapies for and remains a top priority for our business.
Meet Michael Method! He’s been with for more than two years and is the Executive Medical Director for our solid tumor program. He leads the development and ex*****on of our clinical program, tackling strategy, protocol development, compliance, and much more. We’re grateful to have Michael help bridge the gap between scientific research and delivering targeted therapies to patients with .
27/09/2023
1 in 78 women develop and Donna was one of them. She was diagnosed in 2016 and her life changed completely. Since then, she’s made it her mission to raise awareness about this disease – and has shared her story along the way: https://www.youtube.com/watch?v=n8E7ld4ZSsE
Patrick Zweidler-McKay is our Executive Medical Director and has been with for nearly 7 years. He oversees the development of our clinical programs, ensuring that the strategy and trials support the needs of patients facing high-risk blood cancers. We’re thankful for Patrick’s dedication and commitment to bringing to with .
With an unrelenting focus on developing targeted therapies, supports those living with - this month and every month.
September is - a time to honor the 1.5 million people living with or in remission from these diseases in the US. is proud to continue its work in and in hopes of offering to in need. Learn more from The Leukemia & Lymphoma Society: https://www.lls.org/.
September is . that each year, nearly 20,000 women are diagnosed with in the US and just 17% will be diagnosed at an early stage. Join us in raising awareness about the disease by sharing this post so that women living with can have . To learn more, visit Ovarian Cancer Research Alliance OCRA.
Introducing Circles Concierge as a perk! This personal assistance service is designed to lend a helping hand when it comes to personal and professional needs.
can rely on Circles Concierge to do the heavy lifting, so they can focus on bringing to with .
It’s been an exciting 2+ years since Christy Fang joined as our Director of Regulatory Affairs. In this role, Christy acts as the direct connection between ImmunoGen and global regulatory authorities to help bring our targeted therapies to across the world. We’re lucky to have her as part of our team!
Videos (show all)
